Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18080InvestigationalSmall molecule
Unesbulin: Overview.
- Formula / weight
- C19H13F5N6 · 420.347 g/mol (avg)
- Also known as
- 4,6-pyrimidinediamine, 5-fluoro-2-(6-fluoro-2-methyl-1h-benzimidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)- · 5-fluoro-2-(6-fluoro-2-methyl-1h-benzimidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)-4,6-pyrimidinediamine · 5-fluoro-2-(6-fluoro-2-methyl-1h-benzo(d)imidazole-1-yl)-n4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine · 5-fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazole-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine · Bmi1 inhibitor ptc596
- Code names
- PTC-596
Resolves to
Structure
InChIKey
TWLWOOPCEXYVBE-UHFFFAOYSA-NSMILESCC1=NC2=CC=C(F)C=C2N1C1=NC(N)=C(F)C(NC2=CC=C(C=C2)C(F)(F)F)=N1Targets
What you can answer from here — as of April 23, 2025
Which drugs share a target with Unesbulin, and which of those have an active Phase 3 trial?